Furthermore, investigation of UBXN1 mRNA levels in GBM and COAD cell lines demonstrated that PRADX overexpression mediated decrease of UBXN1 expression was abrogated by EZH2 or DDX5 knockdown (Figure 6F). The gene discussed is EZH2; the disease is glioblastoma.